NETSMART TECHNOLOGIES INC
S-8, 2000-02-02
COMPUTER PROCESSING & DATA PREPARATION
Previous: BONE CARE INTERNATIONAL INC, 8-K, 2000-02-02
Next: KEYSTONE AUTOMOTIVE INDUSTRIES INC, SC 13G, 2000-02-02



<TABLE>


     As filed with the Securities and Exchange Commission on February 2, 2000
                                                     Registration No. 333 -
- --------------------------------------------------------------------------------
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                             ----------------------
                                    FORM S-8

             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

                           NETSMART TECHNOLOGIES, INC.
             (Exact name of registrant as specified in its charter)

   Delaware                                                   13-3680154
(State or other jurisdiction of                              (I.R.S. Employer
incorporation or organization)                               Identification No.)

   146 Nassau Avenue
   Islip, New York                                           11751
(Address of Principal Executive Offices)                     (Zip Code)

                          1998 Long-Term Incentive Plan
                              (Full Title of Plan)

                             Asher S. Levitsky P.C.
                        Esanu Katsky Korins & Siger, LLP
                                605 Third Avenue
                            New York, New York 10158
                                 (212) 953-6000
                               Fax: (212) 953-6899
 (Name, address and telephone number, including area code, of agent for service)

                                   Copies to:
           Mr. James L. Conway, President and Chief Executive Officer
                           Netsmart Technologies, Inc.
                                146 Nassau Avenue
                              Islip, New York 11751
                                 (516) 968-2000
                               Fax: (516) 968-2123

                         CALCULATION OF REGISTRATION FEE

<S>                    <C>                <C>                <C>                <C>
                                             Proposed             Proposed
Title of securities                           maximum             maximum
       to be             Amount to be       offering price        aggregate            Amount of
    registered            registered          per unit         offering price     registration fee
- --------------------------------------------------------------------------------------------------
Common Stock, par       500,000 shares        $1.00 (1)           $500,000             $139.00
value $.01 per share

- ----------
(1)     Based on the exercise price of the options granted under the amendment
        to the 1998 Long-Term Incentive Plan which increased the number of
        shares subject to the plan by 500,000 shares.

This Registration Statement also serves as Post-Effective Amendment No. 1 to
Registration Statement on Form S-8, File No. 333-71549, which covered the
Registrant's 1998 Long-Term Incentive Plan, and Post-Effective Amendment No. 2
to the Registration Statement on Form S-8, File No. 333-28287, which covered the
Registrant's 1993 Long-Term Incentive Plan.

</TABLE>
<PAGE>



PROSPECTUS

                                 522,888 Shares
                           NETSMART TECHNOLOGIES, INC.
                                  Common Stock

                   Nasdaq SmallCap Market Trading Symbol: NTST

        The selling  stockholders  may sell up to 522,888 shares of common stock
from time to time. These selling stockholders may sell their shares

        *      On the Nasdaq SmallCap Market.
        *      To a broker-dealer, including a market maker, who purchases the
               shares for its own account.
        *      In private transactions or by gift.

        The selling stockholders may also pledge their shares from time to time,
and the lender may sell the shares upon foreclosure.

        The  shares  are being  offered by the  selling  stockholders  have been
issued or are issuable upon exercise of outstanding options warrants held by the
selling stockholders. We will only receive proceed if any options are exercised.
We will not receive any proceeds  from the sale by the selling  stockholders  of
their shares of common stock.  We will pay the cost of the  preparation  of this
prospectus, which is estimated at $5,000.

                                   ----------

        Investing in shares of our common stock  involves a high degree of risk.
You  should  purchase  the  shares  only if you can  afford to lose your  entire
investment. See "Risk Factors," which begins on page 3.

                                   ----------

        Neither the Securities and Exchange  Commission nor any state securities
commission has approved or disapproved  these  securities or determined  whether
this prospectus is truthful or complete. Any representation to the contrary is a
criminal offense.

                  The date of this Prospectus is January 2, 2000


                                      - 2 -
<PAGE>

                                TABLE OF CONTENTS


                                                                 Page
                                                                 ----
Risk Factors                                                      2
Use of Proceeds                                                   4
Selling Stockholders                                              4
Plan of Distribution                                              6
Available Information                                             6
Incorporation of Certain Documents by Reference                   7
Legal Matters                                                     7
Experts                                                           7


                                  RISK FACTORS

        This prospectus  contains statements that plan or anticipate the future.
Forward-looking  statements  include  statements about our future business plans
and  strategies and the market for our products and most other  statements  that
are not historical in nature. In this prospectus, forward-looking statements are
generally  identified by the words  "anticipate,"  "plan," "believe,"  "expect,"
"estimate" and similar words. Because forward-looking  statements involve future
risks and  uncertainties,  there are factors that could cause actual  results to
differ  materially from those expressed or implied,  including,  but not limited
to, those  identified  under "Risk  Factors" in this  prospectus and in our Form
10-K for 1998,  those  described  in  Management's  Discussion  and  Analysis of
Financial Conditions and Results of Operations in our Form 10-K for 1998 and our
Form 10-Q for the quarter ended  September 30, 1999, and those  described and in
any other filings which are  incorporated  by reference in this  prospectus,  as
well as general economic conditions.

        An  investment in our common stock  involves a high degree of risk.  You
should  consider  carefully,  along with other factors,  the following risks and
should consult with your own legal, tax and financial advisors.

        If we are  unable to obtain  additional  capital,  we may not be able to
develop  our  business  and  perform our  contract  obligations.  We had working
capital of $1.4 million at September 30, 1999. Our cash position  decreased from
$199,000  at December  31, 1998 to $80,000 at  September  30,  1999.  We require
substantial  additional  capital in order to expand and develop our business and
perform our  obligations  under our agreements and purchase  orders.  We have no
commitments  from any person to provide us with any such  capital.  Our business
may suffer significantly if we do not obtain the capital when it is required.

        Because we are dependent upon government contracts,  our business may be
impaired by  policies  relating to  entitlement  programs.  We market our health
information  systems  principally to behavioral health care facilities,  many of
which are  operated by  government  entities and include  entitlement  programs.
During 1998,  we generated  52% of our revenue from  contracts  with  government
agencies,  as  compared  with 35% in 1997 and 31% in 1996.  Government  agencies
generally have the right to cancel contracts at their convenience.  In addition,
we may lose  business if  government  agencies  reduce  funding for  entitlement
programs.

        Our business is based on providing systems relating to behavioral health
organizations,  and changes in government regulation of health care industry may
affect the market for our systems.  We derive  substantially  all of our revenue
from our  health  information  systems  and  services.  The  federal  and  state
governments  have  adopted  numerous  regulations  relating  to the health  care
industry,  including  regulations  relating  to  the  payments  to  health  care
providers  for  various  services,  and our  systems  are  designed  to  provide
information  based on these  requirements.  The adoption of new  regulations can
have a  significant  effect  upon  the  operations  of  health  care  providers,
particularly  those operated by state agencies.  We cannot predict the effect on
our  business of future  regulations  by  governments  and payment  practices by
government  agencies.  Furthermore,  changes in  regulations  in the health care
field may force us to modify  our  health  information  systems  to meet any new
record-keeping  or other  requirements.  If that happens,  we may not be able to
generate revenues sufficient to cover the costs of developing the modifications.

        If we are not able to take  advantage  of  technological  advances,  our
business may suffer. Our customers require software which enables them to store,
retrieve  and process  very large  quantities  of data and to provide  them with
instantaneous communications among the various data bases. Our business requires
us to take advantage of recent advances in software, computer and communications
technology.  This technology has been developing at rapid rates in recent years,
and our future may be  dependent  upon our  ability to use and develop or obtain
rights to products  utilizing such  technology.  New technology may develop in a
manner which may make our software obsolete. Our inability to use new technology
would have a significant adverse effect upon our business.

                                      - 2 -
<PAGE>

        Because  of our  size,  we may have  difficulty  competing  with  larger
companies  that offer  similar  services.  Our  customers in the human  services
market include entitlement programs, managed care organizations,  specialty care
facilities and other major  information  technology  users which have a need for
access to information over a distributed data network.  The software industry in
general, and the health information software business in particular,  are highly
competitive. Other companies have the staff and resources to develop competitive
systems. We may not be able to compete  successfully with such competitors.  The
health information systems business is served by a number of major companies and
a larger  number of smaller  companies,  many of which are  better  capitalized,
better known and have better  marketing  staffs than we have,  and we may not be
able  to  compete  effectively  with  such  companies.  We  believe  that  price
competition  is a  significant  factor  in our  ability  to  market  our  health
information systems and services.

        Because we are  dependent on our  management,  the loss of key executive
officers  could harm our business.  Our business is largely  dependent  upon our
senior  executive  officers,  Messrs.  James  L.  Conway,  president  and  chief
executive  officer,  Anthony  F.  Grisanti,  chief  financial  officer,  John F.
Philips, vice president -- marketing,  and Gerald O. Koop, vice president of the
Company  and chief  executive  officer  of our  operating  subsidiary,  Creative
Socio-Medics Corp. Although we have employment  agreements with Messrs.  Conway,
Grisanti,  Phillips and Koop, these agreement do not guarantee that the officers
will continue with us. Our business may be adversely  affected if any of our key
management personnel or other key employees left our employ.

        Because we lack patent protection, we cannot assure you that others will
not be able to use our proprietary  information in competition  with us. We have
no patent or copyright protection for our proprietary  software,  and we rely on
non-disclosure  agreements  with our employees.  Since our business is dependent
upon our  proprietary  products,  the  unauthorized  use or  disclosure  of this
information could harm our business.

        Our growth may be limited if we cannot make  acquisitions.  An important
part of our growth  strategy is to acquire other  businesses that are related to
our current business.  Such acquisitions may be made with cash or our securities
or a combination of cash and securities.  To the extent that we require cash, we
may have to borrow the funds or issue equity.  We have no  commitments  from any
financing  source and we may not be able to raise any cash necessary to complete
an acquisition.  If we fail to make any  acquisitions,  our future growth may be
limited.  As of the date of this  prospectus,  we do not have any  agreement  or
understanding, either formal or informal, as to any acquisition.

        If we make any acquisitions,  they may disrupt or have a negative impact
on our business. If we make acquisitions,  we could have difficulty  integrating
the acquired companies' personnel and operations with our own. In addition,  the
key  personnel  of the  acquired  business may not be willing to work for us. We
cannot predict the affect expansion may have on our core business. Regardless of
whether we are  successful  in making an  acquisition,  the  negotiations  could
disrupt our ongoing business, distract our management and employees and increase
our expenses.

        We do not anticipate  paying dividends on our common stock. We presently
intend to retain future  earnings,  if any, in order to provide funds for use in
the  operation  and  expansion  of  our  business  and,  accordingly,  we do not
anticipate paying cash dividends on our Common Stock in the foreseeable future.

        The  rights of the  holders  of  common  stock  may be  impaired  by the
potential  issuance of preferred stock.  Our certificate of incorporation  gives
our board of directors the right to create new series of preferred  stock.  As a
result,  the  board  of  directors  may,  without  stockholder  approval,  issue
Preferred Stock with voting, dividend,  conversion,  liquidation or other rights
which could adversely affect the voting power and equity interest of the holders
of common stock.  The preferred  stock,  which could be issued with the right to
more than one vote per share,  could be  utilized  as a method of  discouraging,
delaying or  preventing  a change of control.  The  possible  impact on takeover
attempts could adversely affect the price of our common stock.  Although we have
no present  intention to issue any  additional  shares of preferred  stock or to
create any series of preferred stock, we may issue such shares in the future. If
we issue  preferred  stock in a manner  which  dilutes the voting  rights of the
holders of the common stock,  our listing on The Nasdaq  SmallCap  Market may be
impaired.

        Shares may be issued  pursuant  to  options  which may affect the market
price of our common  stock.  We may issue stock upon the  exercise of options to
purchase  up to an  aggregate 799,192 shares of common stock pursuant to our
long-term incentive plans.

                                 USE OF PROCEEDS

        We will not receive  any  proceeds  from the sale of the shares.  If any
selling stockholders  exercise their options, we will receive the exercise price
of such options.  We will use any such proceeds for working  capital and general
corporate purposes.
                                      - 3 -
<PAGE>
<TABLE>

                              SELLING STOCKHOLDERS

        The following table and discussion sets forth:

        *    the name of each selling stockholder,
        *    the nature of any position,  office or other material relationship,
             if any, which the selling stockholder has had with us or any of our
             affiliates within the last three years,
        *    the number of shares of common stock owned by each selling
             stockholder as of December 31, 1999, * the number of shares of
             common stock  offered for each selling  stockholder's  account,
             and
        *    the percentage owned by each selling stockholder after completion
             of the offering.

<S>                    <C>              <C>                    <C>                      <C>


                            Shares of            Shares of
                          Common Stock         Common Stock             Shares of           Percentage
                           Owned Prior      Offered For Account       Common Stock             Owned
  Selling Stockholder      to Offering     of Selling Stockholder  Owned After Offering     After Offering
  -------------------      -----------     ----------------------  --------------------     --------------
James L. Conway              201,582                 90,000                 111,582              3.6%
John F. Phillips             198,922                101,922                  97,000              3.2%
Edward D. Bright             191,422                106,922                  84,500              2.8%
Gerald O. Koop               152,823                108,223                  44,600              1.5%
Anthony F. Grisanti          123,061                 95,821                  27,240                 *
Joseph G. Sicinski            32,000                 20,000                  12,000                 *

- ----------
*       Less than 1%.

        The  number  of shares of common  stock  owned by each  person  includes
shares of common stock  issuable  upon the exercise of options and warrants that
are currently  exercisable or will become  exercisable within 60 days of January
20, 1999, except as otherwise noted below.

        The  number of shares of common  stock  owned by each  person  after the
offering  assumes that such person exercises all of his options and sells all of
his shares.

        Mr. James L. Conway has been our president and a director since January
1996 and our chief executive officer since April 1998.  Shares owned by Mr.
Conway include (a) 70,000 shares of common stock issuable upon exercise of
options owned by Mr. Conway, (b) 51,333 shares of common stock issuable upon
exercise of the warrants held by Mr. Conway, and (c) 23,916 shares of common
stock issuable upon exercise of warrants held by Mrs. Conway.  Mr. Conway
disclaims beneficial interest in the securities owned by his wife.

        Mr.  Bright has been chairman of the board and a director of the Company
since April 1998. He is also a member of the audit and  compensation  committees
of the board of directors. From January 1996 until April 1998, Mr. Bright was an
executive officer of or advisor to our subsidiary,  Creative  Socio-Medics Corp.
Shares owned by Mr. Bright  include  67,500 shares of common stock issuable upon
the exercise of options.

        Mr.  Phillips  has  been one of our  directors  and  vice  president  of
Creative  Socio-Medics  since June 1994 and our vice  president-marketing  since
1996.  Shares  owned by Mr.  Phillips  include  89,000  shares of  common  stock
issuable upon the exercise of options.

        Mr. Koop has been a director of the Company since June 1998. He has held
management  positions with CSM for more than the past five years,  most recently
as its chief executive  officer, a position he has held since 1996. Shares owned
by Mr. Koop include  87,984 shares of common stock issuable upon the exercise of
options.

        Mr.  Grisanti  has  been  treasurer  of the  Company  since  June  1994,
secretary  since February 1995 and chief  financial  officer since January 1996.
Shares owned by Mr. Grisanti include 85,000 shares of common stock issuable upon
the exercise of options.

        Mr. Sicinski has been a director of the Company since June 1998.  Mr.
Sicinski is a member of the Company's audit and compensation committees of the
board of directors. Shares owned by Mr. Sicinski include 10,000 shares of common
stock issuable upon exercise of options.

                                      - 4 -
</TABLE>
<PAGE>

                              PLAN OF DISTRIBUTION

        The selling stockholders named under the caption "Selling  Stockholders"
may sell up to 522,888  shares of common stock from time to time.  These selling
stockholders may sell their shares

        *      On the Nasdaq SmallCap Market.
        *      To a broker-dealer, including a market maker, who purchases the
               shares for its own account.
        *      In private transactions or by gift.

        The selling  stockholders may also ledge their shares from time to time,
and the lender may sell the shares upon foreclosure.

        The shares of common stock offered by the selling stockholders have been
issued upon exercise of options or are issuable upon exercise of options.

        The selling stockholders may sell the shares at a negotiated price or at
the market price or both.  They may sell their shares directly to the purchasers
or they may use brokers. If they use a broker, the selling  stockholders may pay
a  brokerage  fee or  commission  or they may sell the shares to the broker at a
discount  from the market  price.  The  purchasers  of the shares may also pay a
brokerage fee or other charge.  The  compensation to a particular  broker-dealer
may exceed customary  commissions.  We do not know of any arrangements by any of
the selling stockholders for the sale of any of their shares.

        The  selling   stockholders  and  broker-dealers,   if  any,  acting  in
connection  with  sales  by  the  selling  stockholders  may  be  deemed  to  be
"underwriters"  within the meaning of Section 2(11) of the  Securities  Act, and
any  commission  received  by them and any  profit on the  resale by them of the
securities may be deemed to be underwriting  discounts and commissions under the
Securities Act.

        We have  advised the  selling  stockholders  that the  anti-manipulative
rules under the Exchange Act,  which are set forth in Regulation M, may apply to
their sales in the market.  We have  furnished the selling  stockholders  with a
copy of Regulation M, and we have informed them that they should  deliver a copy
of this prospectus when they sell any shares.

                              AVAILABLE INFORMATION

        We file annual, quarter and periodic reports, proxy statements and other
information  with the Securities and Exchange  Commission using the Commission's
EDGAR system.  You may inspect these documents and copy information from them at
the  Commission's  public  reference  facilities  at  450  Fifth  Street,  N.W.,
Washington,  D.C. 20549 or at the regional offices of the Commission at Citicorp
Center, 500 West Madison Street,  Suite 1400, Chicago,  Illinois 60661 and Seven
World  Trade  Center,  Suite  1300,  New York,  New York  10048.  Copies of such
material can be obtained at prescribed rates from the Public  Reference  Section
of the  Commission  at 450 Fifth  Street,  N.W.,  Washington,  D.C.  20549.  The
Commission  maintains a Web site that contains  reports,  proxy and  information
statements and other information  regarding registrants that file electronically
with the Commission. The address of such site is http//www.sec.gov.

        We have filed a registration  statement with the Commission  relating to
the offering of the shares.  The  registration  statement  contains  information
which  is not  included  in  this  Prospectus.  You  may  inspect  or  copy  the
registration  statement at the Commission's  public reference  facilities or its
website.

        We furnish our  stockholders  with  annual  reports  containing  audited
financial  statements  and with such other  periodic  reports as we from time to
time deems appropriate or as may be required by law. We use the calendar year as
its fiscal year.

        You should rely only on the information contained in this Prospectus and
the information  that we have referred you to. We have not authorized any person
to provide you with any information that is different.

                 INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

        We have  filed  the  following  documents  with the  Commission.  We are
incorporating  these documents in this  prospectus,  and they are a part of this
prospectus.

        (1)    Our Annual  Report on Form 10-K for the year ended  December  31,
               1998, which we amended by three amendments on Form 10-K/A;

                                      - 5 -
<PAGE>

        (2)    Our Quarterly Reports on Form 10-Q for the quarters ended March
               31, 1999, June 30, 1999 and September 30, 1999;

        (3)    Our Proxy Statement for our 1999 Annual Meeting of Stockholders;

        (4)    Our Current Report on Form 8-K, dated March 25, 1999, which we
               filed with the SEC on March 30, 1999; and

        (5)    Our  registration  statement on Form 8-A, which became  effective
               on August 13, 1996.

        We are also  incorporating by reference in this prospectus all documents
which we file  pursuant  to Section  13(a),  13(c),  14 or 15 of the  Securities
Exchange  Act of 1934,  as  amended,  after  the date of this  prospectus.  Such
documents are  incorporated  by reference in this prospectus and are a part this
prospectus from the date we file the documents with the Commission.

        If we file any document with the  Commission  that contains  information
which is different from the information  contained in this  prospectus,  you may
rely  only  on the  most  recent  information  which  we  have  filed  with  the
Commission.

        We will provide a copy of the documents referred to above without charge
if you request the information from us. However,  we may charge you for the cost
of  providing  any  exhibits to any of these  documents  unless we  specifically
incorporate the exhibits in this  prospectus.  You should contact Mr. Anthony F.
Grisanti,  Chief  Financial  Officer,  Netsmart  Technologies,  Inc., 146 Nassau
Avenue, Islip, New York 11751,  telephone (516) 968-2000, if you wish to receive
any of such material.

                                  LEGAL MATTERS

        The validity of the common stock offered  hereby has been passed upon by
our counsel,  Esanu Katsky Korins & Siger, LLP. An attorney who is of counsel at
such firm and the defined  benefit  plan for such  attorney own a total of 4,000
shares of common stock.

                                     EXPERTS

        The consolidated financial statements  incorporated by reference in this
prospectus  to the extent and for the periods  indicated  in their  reports have
been audited by Richard A. Eisner & Company, LLP , independent  certified public
accountants, and Moore Stephens, P.C., independent certified public accountants,
and are included  herein in reliance upon the authority of such firms as experts
in accounting and auditing in giving such reports.

                                      - 6 -
<PAGE>

                                     PART II

               INFORMATION REQUESTED IN THE REGISTRATION STATEMENT

Item 3.  Incorporation of Documents by Relevance.
         ---------------------------------------

        The following documents have been filed by Netsmart Technologies, Inc.
(the "Company") with the Securities and Exchange Commission (the "Commission")
(File No. 0-21177) and are incorporated herein by reference:

        (1)    Our Annual  Report on Form 10-K for the year ended  December  31,
               1998, which we amended by three amendments on Form 10-K/A;
        (2)    Our Quarterly Reports on Form 10-Q for the quarters ended March
               31, 1999, June 30, 1999 and September 30, 1999;
        (3)    Our Proxy Statement for our 1999 Annual Meeting of Stockholders;
        (4)    Our Current Report on Form 8-K, dated March 25, 1999, which we
               filed with the SEC on March 30, 1999;  and (5) Our  registration
               statement on Form 8-A, which became effective on August 13, 1996.

        All documents  subsequently filed pursuant to Sections 13(a),  13(c), 14
and 15 of the  Exchange  Act prior to the filing of a  post-effective  amendment
which indicates that all securities  hereby have been sold or which  deregisters
securities then remaining unsold shall be deemed to be incorporated by reference
in this  Registration  Statement and to be a part hereof from the date of filing
of such documents.

        The exhibit index appears on page II-2 of this Registration Statement.

Item 4. Description of Securities.
        -------------------------

        Not applicable.

Item 5. Interests of Named Experts and Counsel.
        --------------------------------------

        Not applicable

Item 6.  Indemnification of Officers and Directors.
         -----------------------------------------

        Under the Delaware General  Corporation Law ("DGCL"),  a corporation may
indemnify any director,  officer,  employee or agent against expense  (including
attorneys' fees), judgments,  fines and amounts paid in settlement in connection
with any specified threatened,  pending or completed action, suit or proceeding,
whether civil,  criminal,  administrative or investigative (other than an action
by or in the right of the corporation) if such person acted in good faith and in
a manner  such  person  reasonably  believed to be in or not opposed to the best
interests of the corporation,  and, with respect to any criminal proceeding, had
no reasonable cause to believe that his or her conduct was unlawful.

         Article   EIGHTH   of  the   Registrant's   Restated   Certificate   of
Incorporation  provide for  indemnification  of  directors  and  officers of the
Registrant to the fullest extent permitted by the DGCL.

        The Company also maintains  directors and officers  liability  insurance
("D&O  Insurance").  The D&O  Insurance  covers any person who has been or is an
officer  or  director  of the  Company  or of any of its  subsidiaries  for  all
expense,  liability and loss (including  attorneys' fees,  investigation  costs,
judgments,  fines,  penalties  and  amounts  paid or to be  paid in  settlement)
actually and reasonably  incurred by such person in connection with such action,
suit or proceeding, net of the deductible.

        Insofar as indemnification  for liabilities arising under the Securities
Act may be  permitted  to  directors,  offices  or  controlling  persons  of the
Registrant,  pursuant to the foregoing provisions,  or otherwise, the Registrant
has been advised that, in the opinion of the Securities and Exchange Commission,
such  indemnification  is against  public policy as expressed in the  Securities
Act,  and  is,  therefore,   unenforceable.  In  the  event  that  a  claim  for
indemnification  against  such  liabilities  (other  than  the  payment  by  the
Registrant of expenses  incurred or paid by a director,  officer or  controlling
person of the  Registrant  in the  successful  defense  of any  action,  suit or
proceeding)  is  asserted by such  director,  officer or  controlling  person in
connection with the securities being registered hereunder,  the registrant will,
unless in the opinion of its counsel the matter has been settled by  controlling
precedent,  submit to a court of appropriate  jurisdiction  the question whether
such  indemnification  by it is  against  public  policy  as  expressed  in  the
Securities Act and will be governed by the final adjudication of such issue.

                                      II-1

<PAGE>

Item 7.   Exemption from Registration Claimed.
          -----------------------------------

        The Registrant  issued 10,000 shares of common stock to Joseph  Sicinski
in January 2000 upon  exercise of an option.  Mr.  Sicinski is a director of the
Registrant. The issuance of such shares was exempt from registration pursuant to
Section 4(2) of the Securities Act of 1933, as amended.

Item 8.  Exhibits
         --------

          4.1(1)    1993 Long-Term Incentive Plan.
          4.2(2)    1998  Long-Term  Incentive Plan (as amended  through
                    November 3, 1998)
          5.1(3)    Opinion of Esanu Katsky Korins & Siger, LLP.
         23.1       Consent of Richard A. Eisner & Company, LLP (Page II-5)
         23.2       Consent of Moore Stephens, P.C. (Page II-6)
         23.3       Consent of Esanu Katsky Korins & Siger, LLP (contained in
                    Exhibit 5.1 hereto).
         24.1       Power of Attorney (included on the signature page).

- ----------
1       Filed as an exhibit to the Registrant's registration statement on Form
        S-1, File No. 333-2550, which was declared effective by the Commission
        on August 13, 1996.
2       Included as Exhibit A to the Registrant's proxy statement dated
        September 30, 1999, relating to its 1999 Annual Meeting of Stockholders.
3       Filed herewith

Item 9.  Undertakings.
         -------------

        (a)    The undersigned registrant hereby undertakes:

               (1)    To file,  during any  period in which  offers or sales are
                      being   made,   a   post-effective   amendment   to   this
                      Registration Statement:

                      (i)    To include any prospectus required by Section 10(a)
                             (3) of the Securities Act of 1933, as amended
                             (the "Securities Act");

                      (ii)   To reflect in the prospectus any facts or events
                             arising after the effective date of the
                             Registration Statement (or the most recent
                             post-effective amendment thereof) which,
                             individually or in the aggregate, represent a
                             fundamental change in the information set forth
                             in the Registration Statement.  Notwithstanding the
                             foregoing, any increase or decrease in volume of
                             securities offered (if the total dollar value of
                             securities offered would not exceed that which was
                             registered) and any deviation from the low or high
                             end of the estimated maximum offering range may be
                             reflected in the form of prospectus filed with the
                             Commission pursuant to Rule 424(b) if, in the
                             aggregate, the changes in volume and price
                             represent no more than a 20% change in the maximum
                             aggregate offering price set forth in the
                             "Calculation of Registration Fee" table in the
                             effective registration statement;

                      (iii)  To include any material information with respect to
                             the plan of distribution  not previously  disclosed
                             in  the  registration  statement  or  any  material
                             change  to  such  information  in the  registration
                             statement;

                      provided,   however,   that   paragraphs   (a)(1)(i)   and
                      (a)(1)(ii) do not apply if the information  required to be
                      included in a post-effective amendment by those paragraphs
                      is contained in periodic  reports  filed with or furnished
                      to the Commission by the Registrant pursuant to Section 13
                      or Section 15(d) of the Exchange Act that are incorporated
                      by reference in the registration statement.

               (2)    That, for the purpose of determining  any liability  under
                      the  Securities  Act, each such  post-effective  amendment
                      shall  be  deemed  to  be  a  new  registration  statement
                      relating  to  the  securities  offered  therein,  and  the
                      offering of such  securities  at that time shall be deemed
                      to be the initial bona fide offering thereof.

               (3)    To remove from  registration by means of a  post-effective
                      amendment any of the  securities  being  registered  which
                      remain unsold at the termination of the offering.

                                      II-2
<PAGE>


        (b)    The undersigned  registrant  hereby undertakes that, for purposes
               of  determining  any  liability  under the  Securities  Act, each
               filing of the  registrant's  annual  report  pursuant  to Section
               13(a)  or  Section   15(d)  of  the  Exchange  Act  (and,   where
               applicable,  each filing of an  employee  benefit  plan's  annual
               report  pursuant to Section  15(d) of the  Exchange  Act) that is
               incorporated by reference in the registration  statement shall be
               deemed  to  be a  new  registration  statement  relating  to  the
               securities  offered therein,  and the offering of such securities
               at that time shall be deemed to be the initial bona fide offering
               thereof.

        (h)    Insofar as indemnification for liabilities arising under the
               Securities Act may be permitted to directors, officers and
               controlling persons of the registrant pursuant to the foregoing
               provisions, or otherwise, the registrant has been advised that in
               the opinion of the Commission such indemnification is against
               public policy as expressed in the Securities Act and is,
               therefore, unenforceable.  In the event that a claim for
               indemnification against such liabilities (other than the payment
               by the registrant of expenses incurred or paid by a director,
               officer or controlling person of the registrant in the successful
               defense of any action, suit or proceeding) is asserted by
               such director, officer or controlling person in connection with
               the securities being registered, the registrant will, unless in
               the opinion of its counsel the matter has been settled by
               controlling precedent, submit to a court of appropriate
               jurisdiction the question whether such indemnification by it is
               against public policy as expressed in the Securities Act and will
               be governed by the final adjudication of such issue.

                                      II-3

<PAGE>

                                   SIGNATURES

        Pursuant to the  requirements of the Securities Act of 1933, as amended,
the Registrant certifies that it has reasonable grounds to believe that it meets
all  the  requirements  for  filing  on  Form  S-8  and  has  duly  caused  this
Registration Statement to be signed on its behalf by the undersigned,  thereunto
duly  authorized,  in the  Town of  Islip,  State of New York on this 1st day of
February, 2000.

                                            NETSMART TECHNOLOGIES, INC.


                                            By:  /s/ James L. Conway
                                               -------------------------
                                               James L. Conway, President and
                                               Chief Executive Officer

        Pursuant to the  requirements of the Securities Act of 1933, as amended,
this  registration  statement has been signed by the following persons on behalf
of the registrant and in the capacities and on the dates indicated.  Each person
whose signature  appears below hereby  authorizes James L. Conway and Anthony F.
Grisanti or either of them acting in the absence of the others,  as his true and
lawful   attorney-in-fact  and  agent,  with  full  power  of  substitution  and
resubstitution  for  him  and in his  name,  place  and  stead,  in any  and all
capacities to sign any and all amendments (including post-effective  amendments)
to this registration statement,  and to file the same, with all exhibits thereto
and other  documents in connection  therewith,  with the Securities and Exchange
Commission.

Signature                        Title                            Date
- ---------                        -----                            ----

/s/ James L. Conway           President,
- -----------------------       Chief Executive Officer        February 1,  2000
James L. Conway               and Director
(Principal Executive Officer)


/s/ Anthony F. Grisanti       Chief Financial Officer        February 1,  2000
- -----------------------
Anthony F. Grisanti
(Principal Financial
and Accounting Officer)


/s/ Edward D. Bright          Director                       February 1,  2000
- -----------------------
Edward D. Bright


/s/ John F. Phillips          Director                       February 1,  2000
- -----------------------
John F. Philips


                              Director                       February 1,  2000
- -----------------------
Gerald O. Koop


                              Director                       February 1,  2000
- -----------------------
Joseph G. Sicinski


                                      II-4

<PAGE>



               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


   We consent to the incorporation by reference in this  Registration  Statement
on Form S-8 of our report  dated March 23, 1999 (with  respect to Note 17, April
8, 1999) with respect to the financial statements of Netsmart Technologies, Inc.
(the "Company"),  which was included in the Company's Annual Report on Form 10-K
for the year ended  December  31, 1998,  as amended on Form  10-K/A,  and to the
reference to our firm under the heading "Experts" in the prospectus.


                                       RICHARD A. EISNER & COMPANY, LLP
New York, New York
January 26, 2000



<PAGE>



               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


   We consent to the incorporation by reference in this  Registration  Statement
on Form S-8 of our report  dated March 26, 1998 [Except for Note 19, as to which
the date is April 2, 1998], the financial  statements of Netsmart  Technologies,
Inc. (the "Company"),  which was included in the Company's Annual Report on Form
10-K for the year ended December 31, 1997 and  incorporated by reference in this
Registration  Statement,  and to the use of our name,  and the  statements  with
respect to us as appearing under the heading "Experts" in the Prospectus.


                                                MOORE STEPHENS, P.C.
                                                Certified Public Accountants.

Cranford, New Jersey
February 1, 2000






                                                                   Exhibit 5.1

                        Esanu Katsky Korins & Siger, LLP
                                605 Third Avenue
                            New York, New York 10158
                            Telephone: (212) 953-6000
                               Fax: (212) 953-6899

                                February 1, 2000


Securities and Exchange Commission                                    13146-02
450 Fifth Street, N.W.
Washington, D.C. 20549

                             Re:    Netsmart Technologies, Inc.
                                    --------------------------

Ladies and Gentlemen:

        We refer to the  registration  statement on Form S-8 (the  "Registration
Statement"),  filed under the Securities Act of 1933, as amended (the "Act"), by
Netsmart  Technologies,  Inc., a Delaware corporation (the "Company"),  with the
Securities and Exchange  Commission covering the 500,000 shares of the Company's
common stock, par value $.01 per share ("Common  Stock"),  issuable  pursuant to
the amendment to the Company's 1998 Long-Term Incentive Plan (the "Plan").

        We have examined the  originals or  photocopies  or certified  copies of
such records of the Company,  certificates  of officers of the Company and other
documents as we have deemed  relevant  and  necessary as a basis for the opinion
hereinafter expressed.  In such examination,  we have assumed the genuineness of
all signatures,  the authenticity of all documents  submitted to us as certified
copies or  photocopies  and the  authenticity  of the  originals  of such latter
documents.

        Based on our examination described above, we are of the opinion that the
shares of Common Stock  registered  pursuant to the  Registration  Statement are
duly  authorized  and,  when issued upon  receipt of the  exercise  price of the
options granted  pursuant to the Plan,  will be validly  issued,  fully paid and
non- assessable.

        Please note that Asher S. Levitsky, who is of counsel to this firm, and
the Asher S. Levitsky P.C. Defined Benefit Plan, of which Mr. Levitsky is the
trustee and beneficiary, are stockholders of the Company.

        We hereby  consent to the filing of this  opinion as Exhibit  5.1 to the
Registration Statement and to the reference to our firm under "Legal Matters" in
the related Prospectus.  In giving the foregoing consent, we do not hereby admit
that we are in the category of persons whose consent is required under Section 7
of the  Act  or the  rules  and  regulations  of  the  Securities  and  Exchange
Commission.


                                            Very truly yours,


                                            ESANU KATSKY KORINS & SIGER, LLP





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission